Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete ...

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...

New SPECT imaging approach distinguishes inflammation from fibrosis to optimize treatment for lung disease

A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
Healio

Up to 40% of people with heart failure may benefit from therapies targeting inflammation

High inflammatory risk was estimated to be present in nearly 40% of patients with heart failure and was closely tied to ...
Science Daily

This common amino acid helped mice survive deadly inflammation

A Salk Institute study found that a simple dietary amino acid, methionine, dramatically improved survival in mice facing severe infections and inflammatory conditions. Rather than directly targeting ...
Healio

Cardiovascular risk consistent, not elevated across inflammatory bowel disease therapies

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid ...
Science Daily

Inflammation turns bone marrow into a breeding ground for disease

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon ...

How high-intensity interval training alters inflammatory responses

New research published in ImmunoHorizons shows that running a high-intensity interval training (HIIT) workout triggers a more inflammatory immune response than cycling HIIT. These findings could help ...

Ibuprofen for joint pain: what you really need to know

Millions of people in the UK suffer from joint pain and arthritis. But with long wait times for scans, specialist ...
News-Medical.Net

New imaging method distinguishes inflammation from lung fibrosis

A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
Las Vegas Sun

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
Health.com

11 Snacks That Help Calm Inflammation Naturally

Lindsey DeSoto, RD, is a nutrition writer, medical reviewer, and registered dietitian who helps clients improve their diet for health-related reasons. Her writing covers a variety of topics, including ...
Finanznachrichten

Incyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi/Minjuvi) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or ...

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi /Minjuvi) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously ...